Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate Loading Dose for Painful Bone Metastases in Breast Cancer
NCT00381368Phase 2Unknown
- Sponsor
- University of Turku
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibandronate in bone metastases, sponsored by University of Turku. Primary endpoints: Worst and average pain in movement and rest on the visual analogue scale (VAS) at Day 28 and Analgesic consumption at Day 28. Status: unknown.
02
Drugs
ibandronate
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00381368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381368.